Is Square Pharmaceuticals PLC on an FDA import alert?

No listing for Square Pharmaceuticals PLC appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Bangladesh page.

Has FDA refused shipments from Square Pharmaceuticals PLC?

Yes. FDA refused 1 shipment line from Square Pharmaceuticals PLC on November 10, 2025. The most recent, on November 10, 2025, was ashwagandha (herbal & botanicals, not teas), charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse Square Pharmaceuticals PLC's shipments?

The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).

What is Square Pharmaceuticals PLC's FEI number?

Square Pharmaceuticals PLC's FDA Establishment Identifier (FEI) is 3003670128.

Square Pharmaceuticals PLC

FDA import alert and refusal historyGazipur, BangladeshFEI 3003670128

Watch this supplier

As of October 26, 2026, Square Pharmaceuticals PLC is not on any FDA import alert in SupplierRadar's records; FDA refused 1 of its shipment line on November 10, 2025, most often for unapproved new drug (UNAPPROVED).

Data from FDA public records, last checked October 26, 2026. Request a correction

Current status

Import alerts: Not listed
Last import refusal: Nov 10, 2025Ashwagandha (herbal & botanicals, not teas) · UNAPPROVED
Last warning letter: None found
Last inspection: None on record

Every FDA record for Square Pharmaceuticals PLC

1 record, newest first. Each line links to the FDA page it came from.

2025

Nov 10, 2025Import refusal
Refused, Ashwagandha (herbal & botanicals, not teas)UNAPPROVEDEntry AEK-7845871-6
Source

Refusal charges, in plain English

UNAPPROVED1 refused line
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Square Pharmaceuticals PLC

Is Square Pharmaceuticals PLC on an FDA import alert?: No listing for Square Pharmaceuticals PLC appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Bangladesh page.
Has FDA refused shipments from Square Pharmaceuticals PLC?: Yes. FDA refused 1 shipment line from Square Pharmaceuticals PLC on November 10, 2025. The most recent, on November 10, 2025, was ashwagandha (herbal & botanicals, not teas), charged as UNAPPROVED (unapproved new drug).
Why did FDA refuse Square Pharmaceuticals PLC's shipments?: The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).
What is Square Pharmaceuticals PLC's FEI number?: Square Pharmaceuticals PLC's FDA Establishment Identifier (FEI) is 3003670128.

Watch this supplier

Get an email when FDA publishes anything new on Square Pharmaceuticals PLC.

An email with the FDA source, and a dated PDF for your FSVP file. First supplier free.

Watch this supplier

Related records

Guides

Get this record's changes by email

Watch this supplier

Buying from Square Pharmaceuticals PLC?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.